NT-proBNP as predictor of major cardiac events after renal transplantation in patients with preserved left ventricular ejection fraction

[1] Wolfe RAV(1999)Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation and recipients of a first cadaveric transplant N Engl J Med 341 1725-1730

[2] Milforf E(2005)Incidence and predictors of myocardial infarction after kidney transplantation J Am Soc Nephrol 16 496-506

[3] Ojo A(2020)Association of NT-proBNP and BNP with future clinical outcomes in patients With ESKD: a systematic review and meta-analysis Am J Kidney Dis 76 233-247

[4] Ettenger R(2005)B-type natriuretic peptide (BNP) and amino-terminal proBNP in patients with CKD: relationship to renal function and left ventricular hypertrophy Am J Kidney Dis 46 610-620

[5] Agodoa L(2008)Association between n-terminal propeptide b-type natriuretic peptide and markers of hypervolemia Perit Dial Int 28 308-311

[6] Lentine KL(2016)Clinical value of natriuretic peptides in predicting time to dialysis in stage 4 and 5 chronic kidney disease patients Plos One. 11 e0159914-2285

[7] Brennan DC(2012)Brain natriuretic peptide for prediction of mortality in patients with sepsis: a systematic review and meta-analysis Crit Care 16 R74-517

[8] Schnitzler MA(2004)Multi-biomarker risk stratification of n-terminal pro-b-type natriuretic peptide, high-sensitivity c-reactive protein, and cardiac troponin t and i in end-stage renal disease for all-cause death Clin Chem 50 2279-97

[9] Harrison TG(2010)Renal dysfunction, hemodialysis, and the NT-proBNP/BNP ratiothe authors’ reply Am J Clin Pathol 134 516-52

[10] Shukalek CB(2006)Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement J Am Coll Cardiol 47 91-1570

[1] Wolfe RAV(1999)Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation and recipients of a first cadaveric transplant N Engl J Med 341 1725-1730

[2] Milforf E(2005)Incidence and predictors of myocardial infarction after kidney transplantation J Am Soc Nephrol 16 496-506

[3] Ojo A(2020)Association of NT-proBNP and BNP with future clinical outcomes in patients With ESKD: a systematic review and meta-analysis Am J Kidney Dis 76 233-247

[4] Ettenger R(2005)B-type natriuretic peptide (BNP) and amino-terminal proBNP in patients with CKD: relationship to renal function and left ventricular hypertrophy Am J Kidney Dis 46 610-620

[5] Agodoa L(2008)Association between n-terminal propeptide b-type natriuretic peptide and markers of hypervolemia Perit Dial Int 28 308-311

[6] Lentine KL(2016)Clinical value of natriuretic peptides in predicting time to dialysis in stage 4 and 5 chronic kidney disease patients Plos One. 11 e0159914-2285

[7] Brennan DC(2012)Brain natriuretic peptide for prediction of mortality in patients with sepsis: a systematic review and meta-analysis Crit Care 16 R74-517

[8] Schnitzler MA(2004)Multi-biomarker risk stratification of n-terminal pro-b-type natriuretic peptide, high-sensitivity c-reactive protein, and cardiac troponin t and i in end-stage renal disease for all-cause death Clin Chem 50 2279-97

[9] Harrison TG(2010)Renal dysfunction, hemodialysis, and the NT-proBNP/BNP ratiothe authors’ reply Am J Clin Pathol 134 516-52

[10] Shukalek CB(2006)Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement J Am Coll Cardiol 47 91-1570